Multiple appeals have been filed in the Purdue Pharma Chapter 11 bankruptcy case, centering on the issue of the releases being given to the members of the Sackler family that own Purdue. On September 21, United States Trustee William K. Harrington filed a motion...
In a major development in the ongoing opioid litigation involving the State of New York and Nassau and Suffolk counties, on September 9 defendant manufacturer Endo Pharmaceuticals settled for $50 million. Endo reached the settlement amidst allegations that the company...
There have been a number of developments on the opioid litigation front in the last week. Drugmaker Endo Pharmaceuticals and its lawyers from Arnold & Porter are battling allegations that they withheld damaging evidence from the parties by failing to respond to...
The Florida federal judge overseeing the Zantac multidistrict litigation has dismissed all claims, without leave to amend, against manufacturers of ranitidine, the generic or store brand version of the prescription medication Zantac, citing federal law preemption. On...
Opening statements in the sprawling opioids trial pursued by the state of New York and Nassau and Suffolk counties against seven defendant manufacturers and suppliers began on June 29 with four hours of presentations. The case is the first one involving opioids to be...
In a settlement reached on June 26, Johnson & Johnson agreed to pay up to $263 million to the state of New York and Nassau and Suffolk counties to resolve the plaintiffs’ claims that the pharmaceutical giant had contributed to the nationwide opioid crisis that has...
In a 68-page order issued on June 1, the federal judge presiding over the Zofran MDL reversed his 2019 decision and granted GSK’s motion for summary judgment on the basis of pre-emption, essentially ending the multi-district litigation against the pharmaceutical...
In a hearing on March 24 in the Zofran Products Liability MDL, counsel for defendant GlaxoSmithKline asked U.S. District Judge F. Dennis Saylor IV to grants its motion for summary judgment, arguing that the plaintiffs’ own expert failed to make a link between the drug...
U.S. District Judge F. Dennis Saylor IV, who is handling the first bellwether in the MDL that relates to Zofran, has announced the date of October 18th as the potential start of the trial. Plaintiffs allege that Zofran, a drug manufactured by GlaxoSmithKline to ease...
On January 29, the judge presiding over the Valsartan litigation, US District Judge Robert B. Kugler refused to dismiss claims of fraud brought by the consumers against the defendant manufacturers in three master complaints; similar claims against wholesalers and...
